AIA
IBB icon

Allegis Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Allegis Investment Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,208
Closed -$213K – 250
2016
Q3 		$213K Buy
+2,208
New +$210K 0.08% 195
2016
Q1 		– Sell
-24,135
Closed -$2.72M – 512
2015
Q4 		$2.72M Buy
+24,135
New +$2.62M 1.52% 6

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Allegis Investment Advisors's IBB Position: Q4 2016 in Review

Allegis Investment Advisors sold out of iShares Biotechnology ETF (IBB) in Q4 2016, closing a stake of 2,208 shares — an estimated $213K sold.

Allegis Investment Advisors first reported a position in IBB in Q4 2015 and held it in 2 quarters. The position peaked at $2.72M in Q4 2015. 522 funds tracked by Wall St. Rank hold IBB as of Q4 2016.

  • Allegis Investment Advisors reported no remaining iShares Biotechnology ETF position as of Q4 2016 after selling out during the quarter.
  • Allegis Investment Advisors sold 2,208 iShares Biotechnology ETF shares in Q4 2016, an estimated $213K.
  • Allegis Investment Advisors first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 2 quarters.
  • Allegis Investment Advisors's iShares Biotechnology ETF position peaked at $2.72M in Q4 2015.
  • 522 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2016.

Based on Allegis Investment Advisors's 13F filing for Q4 2016, filed 18 Jan 2017.